Indirect effect and pneumococcal conjugate vaccines (Original version in English)

Indirect effect and pneumococcal conjugate vaccines (Original version in English)

Saved in:

Bibliographic Details
Main Author:	L. Temimi
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2009-10-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/965
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indirect effect and pneumococcal conjugate vaccines
by: L. Temimi
Published: (2009-10-01)

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.
by: Uzochukwu Egere, et al.
Published: (2012-01-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
by: Carina Valente, et al.
Published: (2012-01-01)

CONJUGATED PNEUMOCOCCAL VACCINE FOR IMMUNIZATION OF CHILDREN — WHO RECOMMENDATIONS
by: L.S. Namazova
Published: (2007-10-01)

CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
by: A.A. Tarasova, et al.
Published: (2010-09-01)

Evaluation of efficacy and effectiveness across the pneumococcal conjugate vaccine era
by: David C. LaFon
Published: (2025-12-01)

Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru
by: Jorge Alberto Gomez, et al.
Published: (2015-07-01)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
by: Francesca Fortunato, et al.
Published: (2015-01-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012-02-01)

Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial.
by: Hanna Rinta-Kokko, et al.
Published: (2022-01-01)

Preventive Efficacy of Pneumococcal Conjugated Vaccine (Population Aspects)
by: I. N. Protasova, et al.
Published: (2022-01-01)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: David G. McIntosh
Published: (2009-04-01)

Chronicling the Journey of Pneumococcal Conjugate Vaccine Introduction in India
by: Pawan Kumar, et al.
Published: (2025-04-01)

Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
by: Mark van der Linden, et al.
Published: (2020-01-01)

Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.
by: Martin O C Ota, et al.
Published: (2012-01-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

RECOMMENDATION ON THE 7–VALENT PNEUMOCOCCAL CONJUGATED VACCINE AMONG CHILDREN
by: M.V. Fedoseenko, et al.
Published: (2009-06-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
by: Sweta M Patel, et al.
Published: (2022-01-01)

Burden of pneumococcal disease in children in Cuba before the introduction of a novel pneumococcal conjugate vaccine
by: Nivaldo Linares-Pérez, et al.
Published: (2019-10-01)

THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children
by: Edward Mezones-Holguín, et al.
Published: (2014-12-01)

PNEUMOCOCCAL INFECTION. IMMUNIZATION BY A 7-VALENT CONJUGATED PNEUMOCOCCAL VACCINE OF CHILDREN BORN TO HIV-POSITIVE WOMEN
by: L.Yu Afoninа, et al.
Published: (2011-07-01)

The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven-Valent Pneumococcal Conjugate Vaccine
by: Adrienne Morrow, et al.
Published: (2007-01-01)

Pneumococcal Polysaccharide Conjugated Vaccines and the Problem of Changing Circulating Serotypes of Pneumococcus
by: N. N. Kostyukova, et al.
Published: (2023-11-01)

Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
by: S. M. Kharit, et al.
Published: (2016-12-01)

INCIDENCE OF PNEUMOCOCCAL INFECTION IN THE WESTERN EUROPEAN COUNTRIES. INTERNATIONAL EXPERIENCE IN USING SEVEN-VALENT PNEUMOCOCCAL CONJUGATED VACCINE
by: article editorial
Published: (2008-03-01)

Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea
by: Young June Choe, et al.
Published: (2025-12-01)

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population
by: Charalampos Tzanetakos, et al.
Published: (2025-12-01)

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
by: Aurelija Petrutienė, et al.
Published: (2025-08-01)

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review
by: Neil French, et al.
Published: (2019-11-01)

Evaluation of statistical models of carriage to predict the impact of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Nigeria
by: Aishatu L. Adamu, et al.
Published: (2025-08-01)

VACCINATION OF PREMATURE INFANTS AND CHILDREN WITH CONGENITAL HEART DISEASE IN IRKUTSK USING CONJUGATED PNEUMOCOCCAL VACCINES
by: S. V. Il'ina, et al.
Published: (2013-05-01)

Immunogenicity and Safety of 13-valent Conjugated Pneumococcal Vaccine in Patients with Rheumatoid Arthritis
by: B. T. Batozhargalova, et al.
Published: (2024-03-01)

Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
by: Ana Lucia Andrade, et al.
Published: (2017-01-01)

Pneumococcal disease: emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital
by: Enrique Chacon-Cruz, et al.
Published: (2011-12-01)

The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity
by: Rui Yu, et al.
Published: (2020-01-01)